Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses and Long-Term Liabilities (Tables)

v3.20.4
Accrued Expenses and Long-Term Liabilities (Tables)
 9 Months Ended
Sep. 30, 2020
Accrued Expenses And Long-term Liabilities  
Schedule of Other Accrued Expenses

Other accrued expenses consisted of the following as of September 30, 2020 and December 31, 2019:

 

    September 30, 2020     December 31, 2019  
    (unaudited)        
Accrued royalties   $ 2,487     $ 1,934  
Contingent consideration     676       502  
Upfront Medicare payment     2,066       -  
Operating lease liability     1,110       1,321  
Financing lease liability     134       184  
Deferred revenue     69       457  
Payable to CGI     -       888  
Accrued sales and marketing - diagnostics     111       197  
Accrued lab costs - diagnostics     150       163  
Accrued professional fees     1,090       1,399  
Taxes payable     301       403  
Unclaimed property     565       565  
All others     1,372       1,463  
Total other accrued expenses   $ 10,131     $ 9,476  

Schedule of Long Term Liabilities

Long-term liabilities consisted of the following as of September 30, 2020 and December 31, 2019:

 

    September 30, 2020     December 31, 2019  
    (unaudited)        
Warrant liability   $ 20     $ 82  
Uncertain tax positions     4,293       4,081  
Deferred revenue     140       269  
Other     33       141  
Total other long-term liabilities   $ 4,486     $ 4,573